KEYNOTE-042 3-Year Survival Update: 1L Pembrolizumab vs Platinum-Based Chemotherapy for PD-L1+Locally Advanced/Metastatic NSCLC
Date
2021Author
Mok, T. S. K.
Bondarenko, I.
Kubota, K.
Yin, L.
Lin, J.
Souza, F.
Cho, B. C.
Wu, Y.
Lopes, G.
Kudaba, I.
Kowalski, D. M.
Turna, H. Z.
De Castro, G.
Caglevic, C.
Zhang, L.
Karaszewska, B.
Laktionov, K. K.
Srimuninnimit, V.
Metadata
Show full item recordCollections
- Makale [92796]